Seeking Alpha's $843 Bull Case for Lockheed Martin Clashes with DeepValue's Cautious 'WAIT' Stance

What happened

A Seeking Alpha article published on March 30, 2026, argues Lockheed Martin has ~35% upside to $843.21, driven by a $193.6B backlog and strong free cash flow of $6.9B amid rising defense demand. However, DeepValue's latest master report maintains a 'WAIT' rating with a $620 base case, noting the stock trades at a demanding 28.1x P/E and 20.5x EV/EBITDA, pricing in much of the missile-defense ramp narrative already. The report highlights that incremental upside requires concrete conversion of framework agreements into funded, definitized awards for PAC-3 and THAAD programs, not just optimistic headlines. Critical risks include policy constraints on capital returns and the need for a THAAD initial award by FY2026, which the article glosses over despite SEC filings flagging them. Investors should thus view the bullish target with skepticism, focusing instead on auditable disclosures and milestone checks outlined in the DeepValue analysis.

Implication

The article's bullish narrative risks misleading investors by emphasizing backlog and cash flow without addressing the high valuation multiples that limit near-term upside. DeepValue's report underscores that real gains depend on converting PAC-3 and THAAD frameworks into funded contracts, a process fraught with policy and execution hurdles not fully captured in public optimism. Monitoring for SEC disclosures on contract definitization and capital return constraints is crucial, as failure here could trigger a re-rate. The crowded 'missile-defense ramp' trade means any disappointment could lead to sharp corrections, especially given insider selling patterns noted in the report. Ultimately, patience is warranted until clearer evidence of funded awards and sustained FCF above $6.5B emerges, aligning with the report's 6-12 month reassessment window.

Thesis delta

The Seeking Alpha article does not materially shift the investment thesis, as it reiterates known bullish points without new fundamental data or addressing key risks identified in SEC filings. DeepValue's 'WAIT' call remains intact, emphasizing that the thesis hinges on observable contract conversions and policy resilience, not speculative price targets. Investors should ignore superficial optimism and focus on the 90-day checkpoints, such as THAAD award progress and capital return disclosures, to validate any upward move.